Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
40 participants
INTERVENTIONAL
2008-05-31
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Light therapy
light therapy
6 minute light therapy
2
6 minute "session" given with machine "off"
light therapy
combination of wavelengths
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
light therapy
6 minute light therapy
light therapy
combination of wavelengths
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* between ages 18-70 years old
Exclusion Criteria
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nomir Medical Technologies
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nomir Medical Technologies
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alan Robbins, M.D.
Role: STUDY_CHAIR
Nomir Medical Technologies
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Paula Angelini, DPM
Southborough, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Paula Angelini, DPM
Role: primary
Mary Oster
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
07-301
Identifier Type: -
Identifier Source: secondary_id
09.002
Identifier Type: -
Identifier Source: org_study_id